Wearable insulin pump developer EOflow to go public

The company has attracted over 5.5 billion won (US$5.16 million) from local investors including LB Investment, Ideabridge Partners and the state-run Korea Development Bank.

In January, a New York-based nonprofit organization funding type 1 diabetes research JDRF announced it will support EOflow’s insulin delivery system development.

Leave a Reply

Your email address will not be published. Required fields are marked *